Page 18 - Thomas Schneckenburger News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Thomas schneckenburger. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Thomas Schneckenburger Today - Breaking & Trending Today

Molecular Partners Nominates Agnete Fredriksen for Election to Its Board of Directors


Press release content from Accesswire. The AP news staff was not involved in its creation.
Molecular Partners Nominates Agnete Fredriksen for Election to Its Board of Directors
March 11, 2021 GMT
Acknowledged innovation leader with deep scientific and business expertise in immunotherapy, oncology and infectious diseases
ZURICH-SCHLIEREN, SWITZERLAND / ACCESSWIRE / March 11, 2021 / Molecular Partners AG (SIX:MOLN), a clinical-stage biotech company that is developing a new class of custom-built protein drugs known as DARPin® therapeutics, today announced the nomination of Agnete Fredriksen, Ph.D., to the Company’s Board of Directors proposed for election at the 2021 Annual General Meeting on April 21, 2021.
“We are pleased to propose Agnete for election to our Board of Directors during a time of growth and development for Molecular Partners, as we lay the foundations for an infectious diseases portfolio and new technologies for next-generation cancer immunot ....

Shai Biran , Seth Lewis , Thomas Schneckenburger , Bill Burns , Agnete Fredriksen , Company Board Of Directors , Institute Of Immunology , Company On Twitter At Molecularprtnrs , Rikshospitalet Medical Center , Molecular Partners , General Meeting , Molecular Partners Board , Corporate News , Pharmaceutical Manufacturing , Health Care Industry , Executive Changes , Corporate Management , Diseases And Conditions , Infectious Diseases , Medical Biotechnology Industry , Board Of Directors , ஷாய் பிரன் , சேதி லெவிஸ் , ர சி து தீக்காயங்கள் , நிறுவனம் பலகை ஆஃப் இயக்குநர்கள் , நிறுவனம் ஆஃப் நோயெதிர்ப்பு ,

Molecular Partners AG: Molecular Partners Nominates Agnete Fredriksen for Election to Its Board of Directors


Molecular Partners AG: Molecular Partners Nominates Agnete Fredriksen for Election to Its Board of Directors
ZURICH-SCHLIEREN, SWITZERLAND / ACCESSWIRE /
March 11, 2021 / Molecular Partners AG (SIX:MOLN), a clinical-stage biotech company that is developing a new class of custom-built protein drugs known as DARPin
® therapeutics, today
announced the nomination of Agnete Fredriksen, Ph.D., to the Company s Board of Directors proposed for election at the 2021 Annual General Meeting on April 21, 2021.
We are pleased to propose Agnete for election to our Board of Directors during a time of growth and development for Molecular Partners, as we lay the foundations for an infectious diseases portfolio and new technologies for next-generation cancer immunotherapies to fruition, said Bill Burns, chairman of the Molecular Partners Board of Directors. We look forward to benefiting from her breadth of expertise across our deepening portfolio as we continue to expand th ....

Shai Biran , Seth Lewis , Thomas Schneckenburger , Bill Burns , Agnete Fredriksen , Company Board Of Directors , Institute Of Immunology , Company On Twitter At Molecularprtnrs , Rikshospitalet Medical Center , Molecular Partners , General Meeting , Molecular Partners Board , ஷாய் பிரன் , சேதி லெவிஸ் , ர சி து தீக்காயங்கள் , நிறுவனம் பலகை ஆஃப் இயக்குநர்கள் , நிறுவனம் ஆஃப் நோயெதிர்ப்பு , மூலக்கூறு கூட்டாளர்கள் , ஜநரல் சந்தித்தல் , மூலக்கூறு கூட்டாளர்கள் பலகை ,